Literature DB >> 16903918

The regulation of allergy and asthma.

Dale T Umetsu1, Rosemarie H DeKruyff.   

Abstract

Allergic diseases and asthma are caused by exaggerated T-helper 2 (Th2)-biased immune responses in genetically susceptible individuals. Tolerance to allergens is a mechanism that normally prevents such responses, but the specific immunological events that mediate tolerance in this setting are poorly understood. A number of recent studies indicate that regulatory T cells (Tregs) play an important role in controlling such Th2-biased responses. Tregs involved in regulating allergy and asthma consist of a family of related types of T cells, including natural CD25+ Tregs as well as inducible forms of antigen-specific adaptive Tregs. Impaired expansion of natural and/or adaptive Tregs is hypothesized to lead to the development of allergy and asthma, and treatment to induce allergen-specific Tregs could provide curative therapies for these problems.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16903918     DOI: 10.1111/j.0105-2896.2006.00413.x

Source DB:  PubMed          Journal:  Immunol Rev        ISSN: 0105-2896            Impact factor:   12.988


  89 in total

Review 1.  Helper T-cell differentiation and plasticity: insights from epigenetics.

Authors:  Kiyoshi Hirahara; Golnaz Vahedi; Kamran Ghoreschi; Xiang-Ping Yang; Shingo Nakayamada; Yuka Kanno; John J O'Shea; Arian Laurence
Journal:  Immunology       Date:  2011-11       Impact factor: 7.397

2.  A nebulized gelatin nanoparticle-based CpG formulation is effective in immunotherapy of allergic horses.

Authors:  John Klier; Sebastian Fuchs; Anna May; Ulrike Schillinger; Christian Plank; Gerhard Winter; Conrad Coester; Heidrun Gehlen
Journal:  Pharm Res       Date:  2012-06       Impact factor: 4.200

Review 3.  CD4+ T-cell subsets in inflammatory diseases: beyond the Th1/Th2 paradigm.

Authors:  Kiyoshi Hirahara; Toshinori Nakayama
Journal:  Int Immunol       Date:  2016-02-12       Impact factor: 4.823

4.  Altered phosphorylated signal transducer and activator of transcription profile of CD4+CD161+ T cells in asthma: modulation by allergic status and oral corticosteroids.

Authors:  Yael Gernez; Rabindra Tirouvanziam; Khoa D Nguyen; Leonard A Herzenberg; Alan M Krensky; Kari C Nadeau
Journal:  J Allergy Clin Immunol       Date:  2007-10-24       Impact factor: 10.793

Review 5.  Current status of veterinary vaccines.

Authors:  Els N T Meeusen; John Walker; Andrew Peters; Paul-Pierre Pastoret; Gregers Jungersen
Journal:  Clin Microbiol Rev       Date:  2007-07       Impact factor: 26.132

6.  Activation of natural regulatory T cells by IgG Fc-derived peptide "Tregitopes".

Authors:  Anne S De Groot; Leonard Moise; Julie A McMurry; Erik Wambre; Laurence Van Overtvelt; Philippe Moingeon; David W Scott; William Martin
Journal:  Blood       Date:  2008-07-25       Impact factor: 22.113

Review 7.  Helicobacter pylori infection and extragastric disorders in children: a critical update.

Authors:  Lucia Pacifico; John F Osborn; Valeria Tromba; Sara Romaggioli; Stefano Bascetta; Claudio Chiesa
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742

Review 8.  Key mediators in the immunopathogenesis of allergic asthma.

Authors:  Sannette Hall; Devendra K Agrawal
Journal:  Int Immunopharmacol       Date:  2014-06-13       Impact factor: 4.932

9.  A new approach for analyzing cellular infiltration during allergic airway inflammation.

Authors:  Peter R Hoffmann; Alexandra Gurary; Fukun W Hoffmann; Claude Jourdan-Le Saux; Kelsa Teeters; Ann C Hashimoto; Elizabeth K Tam; Marla J Berry
Journal:  J Immunol Methods       Date:  2007-08-27       Impact factor: 2.303

10.  Suppression of murine allergic airway disease by IL-2:anti-IL-2 monoclonal antibody-induced regulatory T cells.

Authors:  Mark S Wilson; John T Pesce; Thirumalai R Ramalingam; Robert W Thompson; Allen Cheever; Thomas A Wynn
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.